ClinicalTrials.govpublic full text
A Longitudinal Study of ACTEMRA® (Tocilizumab) as Monotherapy in Highly Active NMOSD
neuromyelitis optica spectrum disorders, neuromyelitis optica, devic's disease, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 843374
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.